The aging global population, coupled with a rising incidence of sports injuries and orthopedic conditions such as osteoarthritis, further propels market growth.
“According to SNS Insider research, The Orthobiologics Market size was valued at US$ 7.15 billion in 2023 & is anticipated to grow at US$ 11.59 billion by 2032 with compound annual growth rate (CAGR) of 5.55% over the forecast period 2024-2032.”